On July 1, the Federation of American Societies for Experimental Biology (FASEB) welcomed its new President, Thomas O. Baldwin, PhD. Dr. Baldwin is Professor Emeritus of Biochemistry at the University of California, Riverside.
Dr. Baldwin’s lab examined the structural and molecular biology of bacterial luciferase, a class of oxidative enzymes that allows certain marine bacteria to produce bioluminescence. He studied the in vitro folding and assembly of bacterial luciferase subunits, and is also known for cloning bioluminescence genes from marine bacteria and expressing them in the common lab bacterium of e. coli. In addition, Dr. Baldwin’s group was central to a multi-lab effort that determined the three-dimensional protein structure of bacterial luciferase using X-ray diffraction.
Prior to his election as FASEB President, he served as FASEB Vice President for Science Policy and as a member of the FASEB Public Affairs Committee. Dr. Baldwin is Past Chair of the Public Outreach Committee for the American Society for Biochemistry and Molecular Biology (ASBMB), and represented ASBMB on the FASEB Board of Directors. He is also a member of the Protein Society, where he was Secretary-Treasurer.
Dr. Baldwin is a passionate advocate for science, for basic investigator-initiated research, and for the scientific community generally. He feels strongly that the next generation of scientists needs to be empowered not only to do outstanding science, but to communicate the excitement, joy, and significance of scientific discovery to the lay public.
FASEB also welcomes James M. Musser, MD, PhD, as President-Elect; Hannah V. Carey, PhD, as Vice President for Science Policy; and Louis B. Justement, PhD, as Vice President-Elect for Science Policy.
Other new officers serving on the FASEB Board of Directors for 2017-2018 include William B. Farquhar, PhD, FACSM, American College of Sports Medicine; Charles A. Parkos, MD, PhD, American Society for Investigative Pathology; Kelly A. Tappenden, PhD, RD, FASPEN, American Society for Nutrition; Betsy A. Bove, PhD, Association for Molecular Pathology; Kevin C. Kregel, PhD, American Physiological Society; Gerald W. Hart, PhD, Society for Glycobiology; and John B. Morris, PhD, Society for Toxicology. David P. Goldenberg, PhD, of the Protein Society is re-joining the FASEB Board of Directors this year after a break in service.
New members of the FASEB Science Policy Committee for 2017-2018 are Philip E. Bourne, PhD, FACMI, International Society for Computational Biology; Mark DiStefano, PhD, American Peptide Society; Susan L. Forsburg, PhD, ASBMB; and Laura R. McCabe, PhD, American Physiological Society.
In addition, Sheenah M. Mische, PhD, of the Association of Biomolecular Resource Facilities is the new Chair of the Shared Research Resources Subcommittee. Parker B. Antin, PhD, of the American Association of Anatomists will lead the Data Science Informatics Subcommittee.